Home > Insider Trading > Filing (0001567619-18-001512)

Filing Details

Accession Number:: 0001567619-18-001512
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-08-20 21:46:02
Reporting Period:: 2018-08-16

Accepted Time:: 2018-08-20 21:46:02
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1433714	Castlight Health Inc.	CSLT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1278454	C John Doyle	C/O Castlight Health, Inc. 150 Spear St., Suite 400 San Francisco CA 94105	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class B Common Stock	Acquisiton	2018-08-16	7,813	$0.00	207,876	No	4	M	Direct
Class B Common Stock	Acquisiton	2018-08-16	18,750	$0.00	226,626	No	4	M	Direct
Class B Common Stock	Acquisiton	2018-08-16	23,750	$0.00	250,376	No	4	M	Direct
Class B Common Stock	Disposition	2018-08-17	19,024	$2.70	231,352	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class B Common Stock	Restricted Stock Units	Disposition	2018-08-16	7,813	$0.00	7,813	$0.00
Class B Common Stock	Restricted Stock Units	Disposition	2018-08-16	18,750	$0.00	18,750	$0.00
Class B Common Stock	Restricted Stock Units	Disposition	2018-08-16	23,750	$0.00	23,750	$0.00

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
46,875	No	4	M	Direct
150,000	No	4	M	Direct
332,500	No	4	M	Direct

Footnotes

Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on February 26, 2016, the grant of which was previously reported by the Reporting Person on a Form 4.
Release and settlement of RSUs granted to the Reporting Person on July 8, 2016, the grant of which was previously reported by the Reporting Person on a Form 4.
Release and settlement of RSUs granted to the Reporting Person on February 15, 2018, the grant of which was previously reported by the Reporting Person on a Form 4.
Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSU's. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.
Represents the weighted average sales price per share. The shares sold at prices ranging from $2.675 to $2.825 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration.
The RSUs vest over 4 years as follows: 25% of the RSUs vested on February 16, 2017 and the remainder will vest on each quarterly anniversary thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations.
25% of the RSUs vested on August 16, 2017 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations.
The RSUs will vest in equal quarterly installments over four years, beginning on May 16, 2018. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations.